Tourmaline Bio Inc. (TRML)
NASDAQ: TRML
· Real-Time Price · USD
16.42
0.23 (1.42%)
At close: Jul 03, 2025, 3:43 PM
17.36
5.72%
After-hours: Jul 03, 2025, 03:43 PM EDT
1.42% (1D)
| Bid | 15.61 |
| Market Cap | 421.81M |
| Revenue (ttm) | 40K |
| Net Income (ttm) | -82.87M |
| EPS (ttm) | -3.23 |
| PE Ratio (ttm) | -5.08 |
| Forward PE | -3.89 |
| Analyst | Buy |
| Ask | 17.5 |
| Volume | 59,085 |
| Avg. Volume (20D) | 316,663 |
| Open | 16.35 |
| Previous Close | 16.19 |
| Day's Range | 16.11 - 16.52 |
| 52-Week Range | 11.56 - 29.79 |
| Beta | 2.06 |
About TRML
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TRML
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TRML stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-2.59%
TRML stock has given up its prior loss. Tourmaline...
Unlock content with
Pro Subscription
1 month ago
-2.59%
Tourmaline Bio shares are trading lower. The company announced topline results from its ongoing Phase 2 TRANQUILITY trial.
